Duration
Duration
60 months
Funding
Funding
14.9 Mio €
Partners
Partners
11

VISION

EXPERT aims at developing a new off-the-shelf delivery system for RNA-based nanomedicines to treat cancer and cardiovascular disease. In the long term, the platform technology could be used for improving diagnostic and therapeutic options for patients with several other diseases.

Design
Production
Safety & Effifacy
Clincal Study

Our vision is to complement existing clinical studies with mRNA therapeutics and to overcome some of the main obstacles mRNA-based therapy approaches are facing on their way to the market. The EXPERT approach could substantially lower the costs of such treatments enabling their use for more patients and different types of diseases.

Photo of Raymond Schiffelers
Raymond Schiffelers
EXPERT Coordinator